Rutvi Shah

7PUBLICATIONS
113CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 06, 2026
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Francesca Citron, Luca Cecchetto, Elisabetta Granato

|Dec 02, 2025
GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma.

Ziheng Chen, I-Lin Ho, Jintan Liu

|Nov 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence.

Melinda Soeung, Xinmiao Yan, Ciro Zanca

|Nov 01, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer.

Francesca Citron, I-Lin Ho, Chiara Balestrieri

|Mar 27, 2024
Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer.

Alice Cortesi, Francesco Gandolfi, Fabiana Arco

|Mar 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancer.

I-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang

Pageof 2

Frequent Collaborators

6 joint publications

I-Lin Ho

6 joint publications

Er-Yen Yen

6 joint publications

Francesca Citron

6 joint publications

Andrea Viale